Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

INDIGO CARMINE INJECTION 20 MG/5 ML [SIN11374P]

Active ingredients: INDIGO CARMINE INJECTION 20 MG/5 ML

View product's general information
Last updated 24 April 2026

Product Info

INDIGO CARMINE INJECTION 20 MG/5 ML

[SIN11374P]

Product information

Active Ingredient and Strength

INDIGO CARMINE - 4 MG/ML

Dosage Form

INJECTION

Manufacturer and Country

HOSPIRA AUSTRALIA PTY LTD - AUSTRALIA

Registration Number

SIN11374P

Licence Holder

PHEBRA (SE ASIA) PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

V04CH02

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

Indications
Indigo Carmine Injection is used to localise ureteral orifices during cytoscopy and ureteral catheterisation, and as a marker to identify severed ureters and fistulous communications.

Dosing

Dosage and Administration
Indigo Carmine Injection should be administered by intravenous injection. The recommended amount of indigo carmine to be administered to adults is 20 to 40 mg. Indigo carmine should appear in the bladder within 10 to 15 minutes.

Contraindications

Contraindications
Indigo Carmine Injection is contraindicated in patients who have known hypersensitivity to the drug or synthetic dyes.